Clinical Trials Logo

Clinical Trial Summary

Neurodevelopmental impairment due to delayed brain development and brain injury is a fundamental problem in children with critical congenital heart disease (CCHD). Significant longterm motor-, cognitive-, and behavioral problems are the result of early postnatally and perioperatively induced brain injury. Allopurinol, a xanthine oxidase inhibitor, prevents the formation of toxic free oxygen radicals, thereby limiting hypoxia-reperfusion damage. Both animal and neonatal studies suggest that administration of allopurinol reduces hypoxic-ischemic brain injury, is cardioprotective, and safe. This study aims to evaluate the efficacy and safety of allopurinol administered early postnatally and perioperatively in children with a CCHD requiring cardiac surgery with cardiopulmonary bypass.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04217421
Study type Interventional
Source UMC Utrecht
Contact Manon JNL Benders, Prof. MD PhD
Phone 0031887554545
Email m.benders@umcutrecht.nl
Status Recruiting
Phase Phase 3
Start date February 14, 2020
Completion date December 31, 2028

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05975658 - WIReD: Wireless Interstage Remote Device Study
Completed NCT05546983 - How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ?
Completed NCT03229538 - STeroids to REduce Systemic Inflammation After Infant Heart Surgery Phase 3
Completed NCT05579964 - The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot Phase 2/Phase 3
Recruiting NCT04604418 - Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
Recruiting NCT05128084 - Amotosalen and Platelet Transfusion in Pediatric Heart Surgery
Completed NCT05778240 - Adherence to Palivizumab Prophylaxis N/A
Completed NCT04666857 - Family Centred Early Intervention of Infants With Congenital Heart Disease N/A
Terminated NCT03136900 - Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants. N/A
Recruiting NCT05910320 - Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants N/A
Not yet recruiting NCT05778175 - Common Cases in Pediatric Intensive Care in Assuit University Cardiology Institute, a Clinical Audit
Completed NCT05284500 - Predictive Pre and Peroperative Factors for MODS-2 in Pediatric Cardiac Surgery
Completed NCT04295239 - Non-invasive Monitoring of Cerebral Self-regulation in Perioperative Neonatal Cardiac Surgery N/A
Completed NCT05142046 - Influence of Intraoperative Fluid Balance on the Incidence of Adverse Events in Pediatric Cardiac Surgery
Recruiting NCT04040452 - Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery Phase 4
Not yet recruiting NCT06431269 - Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease N/A
Recruiting NCT05268094 - Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial) N/A
Recruiting NCT04315610 - Personalized Mobile App for Parents of Infants With Cardiac Disease N/A
Completed NCT04018079 - Left Ventricular Dysfunction Post-surgical Patent Ductus Arteriosus Ligation in Children: Predictor Factors Analysis
Recruiting NCT05496803 - Impact of Systematic Nursing Guidance on the Psychological Effects of Parents of Children With Cardiac Catheterization. N/A